Is MRI better than CT for detecting a vascular component to dementia? A systematic review and meta-analysis

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Beynon, Rebecca ^a   Sterne, Jonathan A C ^a   Wilcock, Gordon ^c   Likeman, Marcus ^b   Harbord, Roger M ^a   Astin, Margaret ^a   Burke, Margaret ^a   Bessell, Alysson ^a   Ben Shlomo, Yoav ^a   Hawkins, James ^a   Hollingworth, William ^a   Whiting, Penny ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

CT; Dementia; Diagnosis; MRI; Systematic review

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; RISK; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; WHITE MATTER; CEREBROVASCULAR DISEASE; COMORBIDITY; PREVALENCE; REPRODUCIBILITY; REVIEW; RISK ASSESSMENT; STATISTICS;

CEREBROVASCULAR DISORDERS; COMORBIDITY; DEMENTIA; HUMANS; MAGNETIC RESONANCE IMAGING; PREVALENCE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84861837608     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-33     Document Type: Article

References (64)

1. Alzheimer's Association 2011 Alzheimer's Disease Facts and Figures 2011, http://www.alz.org/downloads/Facts_Figures_2011.pdf, Alzheimer's Association.
2. Gifford DR, Holloway RG, Vickrey BG. Systematic review of clinical prediction rules for neuroimaging in the evaluation of dementia. Arch Inter Med 2000, 160:2855-2862.
3. Kirshner HS. Vascular dementia: a review of recent evidence for prevention and treatment. Curr Neurol Neurosci Rep 2009, 9:437-442. 10.1007/s11910-009-0065-y, 19818230.
4. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993, 43:250-260. 10.1212/WNL.43.2.250, 8094895.
5. McKhann G, Drachman D, Folstein M. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984, 34:939-944. 10.1212/WNL.34.7.939, 6610841.
6. National Institute for Clinical Excellence Dementia: Supporting people with dementia and their carers in health and social care 2011, National Insititute for Clinical Excellence, London, National Institute for Clinical Excellence.
7. Geldmacher DS, Whitehouse PJ. Evaluation of dementia. New Eng J Med 1996, 335:330-336. 10.1056/NEJM199608013350507, 8663868.
8. Whiting P, Westwood M, Beynon R, Burke M, Sterne JA, Glanville J. Inclusion of methodological filters in searches for diagnostic test accuracy studies misses relevant studies. J Clin Epidemiol 2010, 64(6):602-607.
9. Leeflang MM, Scholten RJ, Rutjes AW, Reitsma JB, Bossuyt PM. Use of methodological search filters to identify diagnostic accuracy studies can lead to the omission of relevant studies. J Clin Epidemiol 2006, 59:234-240. 10.1016/j.jclinepi.2005.07.014, 16488353.
10. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III) 1980, American Psychiatric Association, Washington, DC, American Psychiatric Association.
11. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III-R) 1987, American Psychiatric Association, Washington, DC, American Psychiatric Association.
12. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) 1994, American Psychiatric Association, Washington, DC, American Psychiatric Association.
13. Chui HC, Victoroff JI, Margolin D, Jagust W, Shankle R, Katzmann R. Criteria for the diagnosis of ischemic vascular dementia proposed by the state of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology 1992, 42:473-480. 10.1212/WNL.42.3.473, 1549205.
14. World Health Organisation The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines 1992, World Health Organisation, Geneva, Switzerland, World Health Organisation.
15. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003, 3:25. 10.1186/1471-2288-3-25, 305345, 14606960.
16. Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA. A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics 2007, 8:239-251.
17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188. 10.1016/0197-2456(86)90046-2, 3802833.
18. Harris RJ, Deeks JJ, Altman DG, Bradburn MJ, Harbord RM, Sterne JAC. metan: fixed- and random-effects meta-analysis. Stata J 2008, 8:3-28.
19. Harbord RM, Whiting P. metandi: Meta-analysis of diagnostic accuracy using hierarchical logistic regression. Stata J 2008, 9:211-229.
20. Harbord RM, Higgins JPT. Meta-regression in Stata. Stata J 2008, 8:493-519.
21. Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 2004, 140:189-202.
22. American Medical Directors Association Dementia in the long-term care setting. 48 2009, American Medical Directors Association (AMDA), Columbia, American Medical Directors Association.
23. Joyce EM, Lishman WA. White matter changes in dementia. Curr Opin Psychiatry 1988, 1:475-479.
24. Landau SM, Harvey D, Madison CM, Reiman EM, Foster NL, Aisen PS, et al. Comparing predictors of conversion and decline in mild cognitive impairment. Neurology 2010, 75:230-238. 10.1212/WNL.0b013e3181e8e8b8, 2906178, 20592257.
25. Mosconi L, McHugh PF. FDG- and amyloid-PET in Alzheimer's disease: is the whole greater than the sum of the parts?. Q J Nucl Med Mol Imaging 2011, 55:250-264. 3290913, 21532539.
26. Barclay LL, Linden C, Murtagh R. Medial temporal atrophy as a magnetic resonance imaging marker for Alzheimer's disease. J Neuroimaging 1992, 2(3):131-135.
27. Del ST, Hachinski V, Merskey H, Munoz DG. Alzheimer's disease with and without cerebral infarcts. J Neurol Sci 2005, 231(1-2):3-11.
28. Ettlin TM, Staehelin HB, Kischka U, Ulrich J, Scollo-Lavizzari G, Wiggli U, et al. Computed tomography, electroencephalography, and clinical features in the differential diagnosis of senile dementia. A prospective clinicopathologic study. Arch Neurol 1989, 46(11):1217-1220. 10.1001/archneur.1989.00520470081031, 2818257.
29. Erkinjuntti T, Haltia M, Palo J, Sulkava R, Paetau A. Accuracy of the clinical diagnosis of vascular dementia: a prospective clinical and post-mortem neuropathological study. J Neurol, Neurosurg Psychiatry 1988, 51(8):1037-1044.
30. Kondo N. A study on the difference between clinical and neuropathological diagnoses of age-related dementing illnesses; correlations with Hachinski's ischemic score. Seishin Shinkeigaku Zasshi - Psychiatria et Neurologia Japonica 1995, 97(10):825-846.
31. Meguro K, Matsushita M, Yoshida R, Otomo E, Yamaguchi S, Nakagawa T, et al. A clinicopathological study of senile dementia of Alzheimer's type (SDAT) and white matter lesions of Binswanger's type. Jpn J Geriatr 1994, 31(3):226-231.
32. Crum TA, Luis CA, Loewenstein DA, Pascal S, Bruce-Gregorius J, Petito C, et al. MRI white matter hyperintensities in Alzheimer's disease (AD) patients do not correlate with vascular disease: A clinico-pathological study. Neurology 2003, 60:65.
33. Amar K, Lewis T, Wilcock G, Scott M, Bucks R. The relationship between white matter low attenuation on brain CT and vascular risk factors: a memory clinic study. Age & Ageing 1995, 24(5):411-415. 10.1093/ageing/24.5.411, 22816095.
34. Barber R, Gholkar A, Scheltens P, Ballard C, McKeith IG, O'Brien JT. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology 1999, 52(6):1153-1158. 10.1212/WNL.52.6.1153, 10214736.
35. Charletta D, Gorelick PB, Dollear TJ, Freels S, Harris Y. CT and MRI findings among African-Americans with Alzheimer's disease, vascular dementia, and stroke without dementia. Neurology 1995, 45(8):1456-1461. 10.1212/WNL.45.8.1456, 7644040.
36. Chen XS. Application of ischemic score of Hachinski in differentiation of multi-infarct dementia. Chung-Hua Shen Ching Ching Shen Ko Tsa Chih [Chinese Journal of Neurology & Psychiatry] 1992, 25((6)):334-37.
37. Engel PA, Gelber J. Does computed tomographic brain imaging have a place in the diagnosis of dementia?. Arch Intern Med 1992, 152(7):1437-1440. 10.1001/archinte.1992.00400190067013, 1627022.
38. Erkinjuntti T, Ketonen L, Sulkava R, Vuorialho M, Palo J. CT in the differential diagnosis between Alzheimer's disease and vascular dementia. Acta Neurol Scand 1987, 75(4):262-270. 10.1111/j.1600-0404.1987.tb07931.x, 3591276.
39. Erkinjuntti T. Differential diagnosis between Alzheimer's disease and vascular dementia: evaluation of common clinical methods. Acta Neurol Scand 1987, 76(6):433-442. 10.1111/j.1600-0404.1987.tb03599.x, 3434201.
40. Erkinjuntti T, Ketonen L, Sulkava R, Sipponen J, Vuorialho M, Iivanainen M. Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer's disease?. J Neurol, Neurosurg Psychiatry 1987, 50(1):37-42.
41. Frisoni GB, Beltramello A, Binetti G, Bianchetti A, Weiss C, Scuratti A, et al. Computed tomography in the detection of the vascular component in dementia. Gerontology 1995, 41(2):121-128.
42. Hagiwara M. A clinical study on the usefulness of CT and MRI imaging in evaluating differential diagnosis and the degree of dementia in vascular dementia. Nippon Ika Daigaku Zasshi - J Nippon Med School 1990, 57(3):265-275.
43. Kertesz A, Polk M, Carr T. Cognition and white matter changes on magnetic resonance imaging in dementia. Arch Neurol 1990, 47(4):387-391. 10.1001/archneur.1990.00530040029015, 2322131.
44. Nagga K, Radberg C, Marcusson J. CT brain findings in clinical dementia investigation-underestimation of mixed dementia. Dement Geriatr Cogn Disord 2004, 18(1):59-66. 10.1159/000077737, 15084796.
45. Purandare N, Oude Voshaar RC, McCollum C, Jackson A, Burns A. Paradoxical embolisation and cerebral white matter lesions in dementia. Br J Radiol 2008, 81(961):30-34.
46. Scheltens P, Kittner B. Preliminary results from an MRI/CT-based database for vascular dementia and Alzheimer's disease. Ann NY Acad Sci 2000, 903:542-546. 10.1111/j.1749-6632.2000.tb06411.x, 10818550.
47. Schroder J, Haan J, Dickmann E. Computerized tomography (CT) in multi-infarct (MID) and dementia of Alzheimer's type (DAT). J Neural Transm - Parkinson's Disease and Dementia Section 1989, 1(1-2):127. 3378837, 22426833.
48. Skoog I, Palmertz B, Andreasson LA. The prevalence of white-matter lesions on computed tomography of the brain in demented and nondemented 85-year-olds. [Review] [53 refs]. J Geriatr Psychiatry Neurol 1994, 7(3):169-175.
49. Staekenborg SS, Koedam EL, Henneman WJ, Stokman P, Barkhof F, Scheltens P, et al. Progression of mild cognitive impairment to dementia: contribution of cerebrovascular disease compared with medial temporal lobe atrophy. Stroke 2009, 40(4):1269-1274. 10.1161/STROKEAHA.108.531343, 19228848.
50. Steingart A, Hachinski VC, Lau C, Fox AJ, Fox H, Lee D, et al. Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (leuko-araiosis). Arch Neurol 1987, 44(1):36-39. 10.1001/archneur.1987.00520130028013, 3800720.
51. Wahlund LO, Basun H, Almkvist O, NderssonLundman G, Julin P, Saaf J. White matter hyperintensities in dementia: does it matter?. Magn Reson Imaging 1994, 12(3):387-394. 10.1016/0730-725X(94)92531-3, 8007767.
52. Wallin A, Blennow K, Uhlemann C, Langstrom G, Gottfries CG. White matter low attenuation on computed tomography in Alzheimer's disease and vascular dementia - Diagnostic and pathogenetic aspects. Acta Neurol Scand 1989, 80(6):518-523. 10.1111/j.1600-0404.1989.tb03920.x, 2618578.
53. Zimny A, Sasiadek M, Leszek J, Czarnecka A, Trypka E, Kiejna A. Does perfusion CT enable differentiating Alzheimer's disease from vascular dementia and mixed dementia? A preliminary report. J Neurol Sci 2007, 257(1-2):114-120.
54. Aharon-Peretz J, Cummings JL, Hill MA. Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size, and leuko-araiosis. Arch Neurol 1988, 45(7):719-721. 10.1001/archneur.1988.00520310025011, 3260480.
55. Butler RE, Costa DC, Greco A, Ell PJ, Katona CLE. Differentiation between Alzheimer's disease and multi-infarct dementia: SPECT vs MR imaging. Int J Geriatr Psychiatry 1995, 10(2):121-128.
56. Du AT, Schuff N, Chao LL, Kornak J, Ezekiel F, Jagust WJ, et al. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol Aging 2005, 26(4):553-559. 10.1016/j.neurobiolaging.2004.05.002, 15653183.
57. Ebmeier KP, Besson JA, Crawford JR, Palin AN, Gemmel HG, Sharp PF, et al. Nuclear magnetic resonance imaging and single photon emission tomography with radio-iodine labelled compounds in the diagnosis of dementia. Acta Psychiatr Scand 1987, 75(5):549-556. 10.1111/j.1600-0447.1987.tb02832.x, 3496733.
58. Endo R. A study of the clinical and the neuroradiological findings in multi-infarct dementia and Alzheimer type dementia. J Tokyo Women's Med Coll 1989, 59(6):693-704.
59. Kobari M, Meyer JS, Ichijo M. Leuko-araiosis, cerebral atrophy, and cerebral perfusion in normal aging. Arch Neurol 1990, 47(2):161-165. 10.1001/archneur.1990.00530020061017, 2302088.
60. Kobari M, Meyer JS, Ichijo M, Oravez WT. Leukoaraiosis: correlation of MR and CT findings with blood flow, atrophy, and cognition. Ajnr: Am J Neuroradiol 1990, 11(2):273-281.
61. Lechner H, Niederkorn K, Schmidt R. Does cerebrovascular insufficiency contribute to Alzheimer's disease?. Ann NY Acad Sci 1991, 640:74-79.
62. London E, de Leon MJ, George AE, Englund E, Ferris S, Gentes C, et al. Periventricular lucencies in the CT scans of aged and demented patients. Biol Psychiatry 1986, 21(10):960-962. 10.1016/0006-3223(86)90270-2, 3741912.
63. Patankar TF, Mitra D, Varma A, Snowden J, Neary D, Jackson A. Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: study in elderly patients with dementia. Ajnr: Am J Neuroradiol 2005, 26(6):1512-1520.
64. Schmidt R. Comparison of magnetic resonance imaging in Alzheimer's disease, vascular dementia and normal aging. Eur Neurol 1992, 32(3):164-169. 10.1159/000116816, 1592074.